tella Inc (2191):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:tella Inc (2191) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9408
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Tella Inc (Tella) is a drug development company that develops vaccines for cancer treatment. The company offers dendritic cell vaccine therapy which develops dendritic cells to convey the information on cancer markers to lymphocytes and increase the dendritic cell population and strengthen the attacking system against cancers. It also develops regenerative medicine and cell medicine for cancer. Tella provides operational support and consultation services. The company offers its therapy for contracted medical institutions in Japan. Tella is headquartered in Tokyo, Japan.

tella Inc (2191) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
tella Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
tella Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
tella Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
tella Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
tella Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
tella Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
OncoTherapy Science and Tella Enter into Co-Development Agreement 10
tella Enters into Research Agreement with Medical Corporation Isokai for Vaccell 11
Tella Enters into Research Agreement with Kitasato Institute 12
AnGes and Tella Enter into Agreement for Joint Research and Development of CIN Therapeutic Vaccine 13
Equity Offering 14
tella Plans to Raise USD8.7 Million in Private Placement of Shares 14
Kohjin Bio Raises USD1.7 Million in Private Placement of Shares 15
Acquisition 16
tella Sells 44.4% Stake in Osaka-Based Cell Processing Facilities Consolidated Subsidiary for USD1 Million 16
tella Acquires Bioimmulance 17
tella Inc – Key Competitors 18
tella Inc – Key Employees 19
tella Inc – Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
tella Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
tella Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
tella Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
tella Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
tella Inc, Deals By Therapy Area, 2012 to YTD 2018 8
tella Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
OncoTherapy Science and Tella Enter into Co-Development Agreement 10
tella Enters into Research Agreement with Medical Corporation Isokai for Vaccell 11
Tella Enters into Research Agreement with Kitasato Institute 12
AnGes and Tella Enter into Agreement for Joint Research and Development of CIN Therapeutic Vaccine 13
tella Plans to Raise USD8.7 Million in Private Placement of Shares 14
Kohjin Bio Raises USD1.7 Million in Private Placement of Shares 15
tella Sells 44.4% Stake in Osaka-Based Cell Processing Facilities Consolidated Subsidiary for USD1 Million 16
tella Acquires Bioimmulance 17
tella Inc, Key Competitors 18
tella Inc, Key Employees 19

List of Figures
tella Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
tella Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
tella Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
tella Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
tella Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
tella Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
tella Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
tella Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[tella Inc (2191):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MOIL Ltd:企業の戦略・SWOT・財務分析
    MOIL Ltd - Strategy, SWOT and Corporate Finance Report Summary MOIL Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Land Securities Group Plc:企業のM&A・事業提携・投資動向
    Land Securities Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Land Securities Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • STMicroelectronics NV (STM):医療機器:M&Aディール及び事業提携情報
    Summary STMicroelectronics NV (STM) is a semiconductor company. It develops, manufactures, and markets a wide range of products, including discrete and standard commodity components, full custom devices and semi-custom devices and application-specific standard products, and application-specific inte …
  • Morrison & Foerster LLP:企業の戦略的SWOT分析
    Morrison & Foerster LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Goodman Group:企業のM&A・事業提携・投資動向
    Goodman Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Goodman Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • ALK-Abello AS (ALK B):製薬・医療:M&Aディール及び事業提携情報
    Summary ALK-Abello AS (ALK), a subsidiary of The Lundbeck Foundation discovers, develops and commercializes immunotherapies for allergy prevention and treatment. It markets diagnostics and other services to allergy clinics. The company's allergy immunotherapy product portfolio includes tablet-based …
  • Sonova Holding AG (SOON):企業の財務・戦略的SWOT分析
    Sonova Holding AG (SOON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Parion Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Parion Sciences Inc (Parion Sciences) is a development stage company that provides research, development and commercialization of treatments to improve patient’s innate mucosal surface defenses. The company’s pipeline products include P-1037, a clinical stage ENaC blocker for pulmonary disea …
  • Nachi-Fujikoshi Corp.
    Nachi-Fujikoshi Corp. - Strategy, SWOT and Corporate Finance Report Summary Nachi-Fujikoshi Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • JGC Holdings Corp (1963)
    JGC Holdings Corp (1963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Savanna Energy Services Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Savanna Energy Services Corp (Savanna), a subsidiary of Total Energy Services Inc, is an oilfield service provider that offers drilling, well servicing and oilfield rental services. The company conducts drilling, hybrid drilling, and well servicing and oilfield services such as oilfield equi …
  • Ensign Energy Services Inc (ESI):企業の財務・戦略的SWOT分析
    Summary Ensign Energy Services Inc (Ensign Energy) is an oil and gas company that offers oilfield services. The company’s services include directional drilling, horizontal drilling, well servicing and testing services. It provides well completions and recompletions, abandonment of redundant wells, s …
  • Advance Auto Parts, Inc.:企業の戦略・SWOT・財務分析
    Advance Auto Parts, Inc. - Strategy, SWOT and Corporate Finance Report Summary Advance Auto Parts, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Romelectro S.A.:企業の戦略的SWOT分析
    Romelectro S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Occidental Chemical Corp:企業の戦略的SWOT分析
    Occidental Chemical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Bioorganic Research and Services SA (BNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioorganic Research and Services SA (Bionaturis) is a biotechnology company that develops non-prescription products for production animals and pets. The company offers products such as BNT006, BNT007, BNT010, BNT015 and BNT005. It provides non-therapeutic and therapeutic products for poultry …
  • Halo Pharma Inc-製薬・医療分野:企業M&A・提携分析
    Summary Halo Pharma Inc (Halo) is a contract development and manufacturing organization which offers scientific and development expertise services. It offers project management, formulation development and analytical development services. The organization holds specialization in the development of m …
  • BCD Travel Services B.V.:戦略・SWOT・企業財務分析
    BCD Travel Services B.V. - Strategy, SWOT and Corporate Finance Report Summary BCD Travel Services B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Lassila & Tikanoja plc:企業のM&A・事業提携・投資動向
    Lassila & Tikanoja plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Lassila & Tikanoja plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • TAP Biosystems Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary TAP Biosystems Ltd (TAP), a subsidiary of Sartorius Stedim Biotech GmbH is a provider of laboratory and pharmaceutical equipment. The company designs and manufactures automated cell culture, bio-reactor systems and fermentation systems. It also provides labware, consumables and accessories. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆